Live feed
Filing
SC 13G
SC 13G0001085146-15-000613·Consonance Capital Management LP
Schedule 13G ownership disclosure
Protalix BioTherapeutics, Inc.
Security class unavailable · CUSIP: 74365A101
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,027,338
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-15-000613
- Form type
- SC 13G
- Filer
- Consonance Capital Management LP
- CIK
- CIK 1544773
- Filed
- Feb 17, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership